What is the recommended dose and infusion rate for a continuous atropine infusion in an adult patient?

Atropine Infusion Dosing for Organophosphate/Carbamate Poisoning

For severe organophosphate or carbamate poisoning requiring continuous atropine infusion, double the initial bolus dose every 5 minutes until full atropinization is achieved (clear chest on auscultation, heart rate >80/min, systolic blood pressure >80 mm Hg), then maintain atropinization with a continuous infusion 1.

Initial Bolusing Strategy

The 2023 American Heart Association guidelines provide the most authoritative approach 1:

• Start with higher-than-typical atropine doses for life-threatening poisoning (bronchospasm, bronchorrhea, seizures, significant bradycardia)
• Double the dose every 5 minutes until atropinization endpoints are met
• Target endpoints for full atropinization:
  • Clear chest on auscultation (no bronchorrhea/bronchospasm)
  • Heart rate >80 beats/min
  • Systolic blood pressure >80 mm Hg

Maintenance Infusion

Once atropinization is achieved, transition to continuous infusion to maintain atropinization 1. While the AHA guideline doesn't specify exact infusion rates, research evidence provides practical guidance:

• Studies describe infusion rates up to 30 mg/hour for patients failing to respond adequately 2
• The infusion rate should be titrated to maintain atropinization endpoints rather than using a fixed dose
• Typical maintenance may require 10-20% of the total bolus dose used to achieve atropinization, given per hour

Special Considerations and Pitfalls

Coronary artery disease limitation: If the patient has known coronary disease, limit total atropine to 0.03-0.04 mg/kg (approximately 2-3 mg maximum) to avoid tachycardia-induced myocardial ischemia 3. However, this creates a clinical dilemma in severe poisoning where much higher doses are needed.

Inadequate response protocol: If target heart rate (>100/min) or blood pressure cannot be achieved despite high-dose atropine (cumulative 100 mg within 6 hours or infusion of 30 mg/hour for 3+ hours), add adrenaline infusion at 2-4 μg/min 2. This combination effectively reverses inadequate hemodynamic response.

Continuous infusion advantages: Research demonstrates that continuous micropump infusion versus intermittent boluses results in 4:

• More stable vital signs
• Lower total atropine dose required
• Reduced atropine toxicity incidence
• Shorter cholinesterase reactivation time
• Higher cure rates

Monitoring for atropine toxicity: Watch for hyperthermia, delirium, urinary retention, and mydriasis. The continuous infusion approach actually reduces toxicity risk compared to repeated large boluses 4, 5.

Clinical Algorithm

1. Recognize severe poisoning (bronchospasm, bronchorrhea, bradycardia, seizures)
2. Give atropine boluses, doubling every 5 minutes until atropinization
3. Calculate hourly infusion rate based on total bolus dose needed (typically 10-20% per hour)
4. Titrate infusion to maintain clear chest, HR >80, SBP >80
5. If inadequate response despite 30 mg/hour × 3 hours, add adrenaline 2-4 μg/min
6. Monitor continuously for both under-atropinization and atropine toxicity

The evidence strongly supports aggressive, high-dose atropine therapy with continuous infusion for maintenance, as mortality reduction is significant (from 23.5% to 8.8%) with this approach 5.